HFHS Electronic Medical Records compared to HFHS PLCO data |
Melody Eide |
Henry Ford Health System |
PLCO |
Sep 9, 2014 |
PLCO-105 |
The influence of inflammatory diets on the incidence of colorectal cancer, with special consideration of race and obesity |
Alyson Haslam |
University of Georgia |
PLCO |
Sep 4, 2014 |
PLCO-104 |
Prospective Evaluation of Immune-related Markers and Gallbladder Cancer |
Jill Koshiol |
DCEG - Other |
PLCO |
Sep 3, 2014 |
2014-0198 |
Circulation miRNA for Pancreatic Cancer Early Detection and Risk Assessment |
Xiao Ou Shu |
- |
PLCO |
Sep 3, 2014 |
2014-0190 |
Endogenous Hormone Levels and Risk of Liver Cancer |
Katherine McGlynn |
NCI, DCEG, HREB |
PLCO |
Sep 3, 2014 |
2014-0187 |
Development of a personalized lung cancer risk prediction model |
Pinchas Akiva |
Medial-Research |
PLCO |
Aug 26, 2014 |
PLCO-103 |
Impact of Prostate Cancer Screening on Behavior Modifications and Racial Disparities |
Michael Liss |
University of Texas Health Science Center San Antonio |
PLCO |
Aug 15, 2014 |
PLCO-100 |
CRC Incidence in Subjects with Surveillance Colonoscopy by Age |
Paul Pinsky |
NCI |
PLCO |
Aug 14, 2014 |
PLCO-102 |
Molecular pathological epidemiology of colorectal cancer |
Ulrike Peters |
Fred Hutchinson Cancer Center |
PLCO |
Jul 22, 2014 |
PLCO-98 |
Quantifying the Clinical Utility of the Digital Rectal Exam in the Age of PSA Screening |
Ryan Terlecki |
Wake Forest Baptist Medical Center |
PLCO |
Jul 17, 2014 |
PLCO-97 |
Analysis of genetic variants and lung cancer risk and prognosis |
Qingyi Wei |
Duke Cancer Institute |
PLCO |
Jul 17, 2014 |
PLCO-95 |
Flexible sigmoidoscopy screening in colorectal cancer: A pooled analysis of randomized controlled trials |
Robert Schoen |
University of Pittsburgh |
PLCO |
Jul 8, 2014 |
PLCO-94 |
An analysis of body mass index trajectories in relation to esophageal and gastric cardia adenocarcinoma in the PLCO and NIH-AARP cohorts |
Michael Cook |
NCI, DCEG, HREB |
PLCO |
Jun 23, 2014 |
PLCO-92 |
Upgrading and upstaging of men with clinically low-risk prostate cancer in PLCO |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jun 23, 2014 |
PLCO-93 |
Fat intake modifies the association between smoking and lung cancer risk |
Jianjun Zhang |
Indiana University |
PLCO |
May 30, 2014 |
PLCO-87 |
Use of Regression Discontinuity to Measure the Effect of PSA Screening |
Jonathan Shoag |
None |
PLCO |
May 28, 2014 |
PLCO-90 |
Effect of screening on colorectal cancer incidence and mortality associated with smoking, obesity and family history of colorectal cancer |
Adeyinka Laiyemo |
Howard University |
PLCO |
May 27, 2014 |
PLCO-88 |
Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data |
Dongfeng Wu |
University of Louisville |
PLCO |
May 21, 2014 |
PLCO-86 |
ovarian cancer screening in a high risk population |
Keith Terada |
University of Hawaii |
PLCO |
May 21, 2014 |
PLCO-89 |
The implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis and cancer-specific mortality |
Nora Pashayan |
University College London |
PLCO |
May 20, 2014 |
PLCO-85 |